FDA tells Purell to stop claiming it can prevent flu

Marketing campaign also claims product can prevent ebola spread


The Food and Drug Administration (FDA) told the maker of Purell to discontinue marketing campaigns that includes claims for avoiding flu and ebola, according to an article on The New York Times website.

The campaigns also claim the product can prevent spread of MRSA and norovirus.

The FDA told Gojo Industries that its claims that Purell could reduce the potential for infection or prevent illnesses violated the Federal Food, Drug and Cosmetic Act. 

The agency said it was reclassifying Purell as an unapproved drug, rather than an over-the-counter product.

Read the article.



February 10, 2020


Topic Area: Infection Control

Recent Posts

Making the Energy Efficiency Case to the C-Suite

Hospital executives often wrestle with energy decisions made today that either free up budget for patient care or drain resources that could go elsewhere.

How to Avoid HAIs This Flu Season

There are risks surrounding hospitalizations. Here’s how to avoid them.

Design Phase Set to Begin for Hospital Annex at SUNY Upstate Medical

The design will feature a new, expanded emergency department and burn unit to serve the Central New York Region.

Building Hospital Resilience in an Era of Extreme Weather

Expert Jennifer Mahan discusses the vulnerabilities healthcare facilities face during disasters and the infrastructure strategies that keep operations running.

Ennoble Care Falls Victim to Data Breach

Their investigation into the incident is still ongoing.

 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.